ProQR Therapeutics N.V. (PRQR) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Vogenx is the larger company by market cap ($260.9 million vs $230.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PRQR | VOGX |
|---|---|---|
| Share price | $1.63 | $17.56 |
| Market cap | $230.02M | $260.86M |
| 1-day change | +3.82% | +0.40% |
| YTD return | -19.31% | — |
| 1-year return | -34.80% | — |
| 5-year return | -79.31% | — |
| EPS (TTM) | $-0.45 | $-0.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.10 | $38.41 |
| 52-week low | $1.33 | $12.95 |
| Distance from 52-week high | -47.42% | -54.28% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +377.30% | +213.21% |
| Average volume | 796.41K | 187.66K |
| Shares outstanding | 141.12M | 14.86M |
| Employees | 186 | 4 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ProQR Therapeutics N.V.
PRQR stock →ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs.
Health Care · Biotechnology: Pharmaceutical Preparations · 186 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
PRQR vs VOGX FAQ
Which is bigger, ProQR Therapeutics N.V. or Vogenx?
Vogenx (VOGX) is larger, with a market capitalization of $260.86M compared with $230.02M for ProQR Therapeutics N.V. (PRQR).
Are ProQR Therapeutics N.V. and Vogenx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.